PB-1 (Pangaea Biotech)

N/A

Report date: 2025/01/15 13:54:33
NME

Base Information

Drug NamePB-1 (Pangaea Biotech)
Drug Alias NamePB-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiscoidin domain-containing receptor 2 inhibitors
TargetsDiscoidin domain-containing receptor 2
Therapy Area/IndicationsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPangaea Biotech SA
China Registration ClassN/A

Develop Information

Active CompaniesPangaea Biotech SA
Inactive CompaniesN/A
Active IndicationsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A